Qualigen Therapeutics, Inc. — Director's Dealing 2017

Oct 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2017-10-03

Reporting Person: Javelin Venture Partners, L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-03	Common Stock	P	5000000	—	Acquired	7047804	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-03	Warrants (right to buy)	$.44	P	5000000	Acquired	2022-10-03	Common Stock (5000000)	Direct

Footnotes

F1: The Reporting Person purchased 5,000,000 Class A Units of the Issuer, consisting of 5,000,000 shares of common stock and warrants to purchase 5,000,000 shares of common stock, in the Issuer's October 2017 public offering at the public offering price of $0.40 per Class A Unit. The shares of common stock and warrants that are part of the Class A Units sold to the Reporting Person in the puble offering were immediately separable and were issued separately in the offering.